Exosome-mediated therapeutic delivery: a new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement)

Neurodegenerative disorders are one of the leading causes of death and disability worldwide, which also poses major burden on health care systems. siRNA opens a new perspective to treat diseases pertaining to gene functions by silencing its targeted mechanisms. Exosome-mediated siRNA is a newly deve...

Full description

Saved in:
Bibliographic Details
Main Authors: Seyfizadeh, Nayer (Author) , Seyfizadeh, Narges (Author)
Format: Article (Journal)
Language:English
Published: 02 July 2019
In: Process biochemistry
Year: 2019, Volume: 85, Pages: 164-174
ISSN:0032-9592
DOI:10.1016/j.procbio.2019.06.025
Online Access:Verlag, Volltext: https://doi.org/10.1016/j.procbio.2019.06.025
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S1359511319304738
Get full text
Author Notes:Nayer Seyfizadeh, Narges Seyfizadeh, Sajad Borzouisileh, Farideh Elahimanesh, Vahid Hosseini, Mohammad Nouri

MARC

LEADER 00000caa a2200000 c 4500
001 1685124569
003 DE-627
005 20230427200425.0
007 cr uuu---uuuuu
008 191211s2019 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.procbio.2019.06.025  |2 doi 
035 |a (DE-627)1685124569 
035 |a (DE-599)KXP1685124569 
035 |a (OCoLC)1341281390 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Seyfizadeh, Nayer  |e VerfasserIn  |0 (DE-588)120142447X  |0 (DE-627)1685125026  |4 aut 
245 1 0 |a Exosome-mediated therapeutic delivery  |b a new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement)  |c Nayer Seyfizadeh, Narges Seyfizadeh, Sajad Borzouisileh, Farideh Elahimanesh, Vahid Hosseini, Mohammad Nouri 
264 1 |c 02 July 2019 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.12.2019 
520 |a Neurodegenerative disorders are one of the leading causes of death and disability worldwide, which also poses major burden on health care systems. siRNA opens a new perspective to treat diseases pertaining to gene functions by silencing its targeted mechanisms. Exosome-mediated siRNA is a newly developed unique approach in order to improve the efficiency of siRNA delivery system. This method is potentially a convenient scheme for CNS disorders, because of its therapeutic based delivery mechanistic approach across the blood-brain barrier (BBB). Exosomes are extracellular nanostructures that could carry a variety of cargoes and performs many different functions based on their origin. Exosomes. In this review, we mainly focus on the third application and discuss exosome biogenesis and its therapeutic applications in neurodegenerative disorders. We summarize the latest studies on how exosome improves small RNA therapy and give an overview of exosome cargo loading techniques, its source cell selection, and efficient delivery routes. 
650 4 |a CNS diseases 
650 4 |a Exosome 
650 4 |a Gene therapy 
650 4 |a Neurodegenerative disease 
650 4 |a siRNA 
700 1 |a Seyfizadeh, Narges  |e VerfasserIn  |0 (DE-588)1181446643  |0 (DE-627)166266995X  |4 aut 
773 0 8 |i Enthalten in  |t Process biochemistry  |d Amsterdam [u.a.] : Elsevier Science, 1991  |g 85(2019), Seite 164-174  |h Online-Ressource  |w (DE-627)320570916  |w (DE-600)2016483-X  |w (DE-576)259484989  |x 0032-9592  |7 nnas  |a Exosome-mediated therapeutic delivery a new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement) 
773 1 8 |g volume:85  |g year:2019  |g pages:164-174  |g extent:11  |a Exosome-mediated therapeutic delivery a new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement) 
856 4 0 |u https://doi.org/10.1016/j.procbio.2019.06.025  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S1359511319304738  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20191211 
993 |a Article 
994 |a 2019 
998 |g 1181446643  |a Seyfizadeh, Narges  |m 1181446643:Seyfizadeh, Narges  |d 910000  |e 910000PS1181446643  |k 0/910000/  |p 2 
999 |a KXP-PPN1685124569  |e 3563559007 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"Process biochemistry","title":"Process biochemistry"}],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1991-","publisher":"Elsevier Science ; Science Direct","dateIssuedKey":"1991"}],"id":{"zdb":["2016483-X"],"eki":["320570916"],"issn":["0032-9592","1359-5113"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Exosome-mediated therapeutic delivery a new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement)Process biochemistry","physDesc":[{"extent":"Online-Ressource"}],"recId":"320570916","language":["eng"],"pubHistory":["Nachgewiesen 26.1991 -"],"part":{"pages":"164-174","year":"2019","extent":"11","volume":"85","text":"85(2019), Seite 164-174"}}],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen"}],"name":{"displayForm":["Nayer Seyfizadeh, Narges Seyfizadeh, Sajad Borzouisileh, Farideh Elahimanesh, Vahid Hosseini, Mohammad Nouri"]},"id":{"doi":["10.1016/j.procbio.2019.06.025"],"eki":["1685124569"]},"origin":[{"dateIssuedDisp":"02 July 2019","dateIssuedKey":"2019"}],"recId":"1685124569","language":["eng"],"note":["Gesehen am 11.12.2019"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Nayer","family":"Seyfizadeh","role":"aut","roleDisplay":"VerfasserIn","display":"Seyfizadeh, Nayer"},{"family":"Seyfizadeh","given":"Narges","display":"Seyfizadeh, Narges","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"Exosome-mediated therapeutic delivery","subtitle":"a new horizon for human neurodegenerative disorders’ treatment (with a focus on siRNA delivery improvement)","title_sort":"Exosome-mediated therapeutic delivery"}]} 
SRT |a SEYFIZADEHEXOSOMEMED0220